![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hugman Bruce
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.11, 2012-11, pp. : 1005-1025
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety and risk communication to patients
Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risk communication in the clinical consultation
By Thomson Richard Edwards Adrian Grey Jenny
Clinical Medicine, Vol. 5, Iss. 5, 2005-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Focusing on Risk Communication About Medicines: Why Now?
By Bahri Priya
Drug Safety, Vol. 35, Iss. 11, 2012-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risk communication: the science behind safety warnings
Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
US FDA lays out strategy for risk communication
Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. :